DE3878231D1 - Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung. - Google Patents

Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung.

Info

Publication number
DE3878231D1
DE3878231D1 DE8888901838T DE3878231T DE3878231D1 DE 3878231 D1 DE3878231 D1 DE 3878231D1 DE 8888901838 T DE8888901838 T DE 8888901838T DE 3878231 T DE3878231 T DE 3878231T DE 3878231 D1 DE3878231 D1 DE 3878231D1
Authority
DE
Germany
Prior art keywords
ser
cadiodilatin
fragment
new
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888901838T
Other languages
English (en)
Other versions
DE3878231T2 (de
Inventor
Wolf-Georg Forssmann
M Alt
Gerhard Becker
Franz Herbst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharis Biotec GmbH
Original Assignee
Bissendorf Peptide GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19873706731 external-priority patent/DE3706731A1/de
Priority claimed from DE19873717329 external-priority patent/DE3717329A1/de
Application filed by Bissendorf Peptide GmbH filed Critical Bissendorf Peptide GmbH
Priority to DE8888901838T priority Critical patent/DE3878231T2/de
Publication of DE3878231D1 publication Critical patent/DE3878231D1/de
Application granted granted Critical
Publication of DE3878231T2 publication Critical patent/DE3878231T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
DE8888901838T 1987-03-02 1988-02-27 Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung. Expired - Lifetime DE3878231T2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE8888901838T DE3878231T2 (de) 1987-03-02 1988-02-27 Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung.

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE19873706731 DE3706731A1 (de) 1987-03-02 1987-03-02 Neues cardiodilatinfragment und verfahren zur gewinnung von cardiodilatinfragmenten
DE19873717329 DE3717329A1 (de) 1987-05-22 1987-05-22 Neues cardiodilatinfragment, verfahren zu seiner gewinnung und seine verwendung
DE3741641 1987-12-09
PCT/EP1988/000144 WO1988006596A1 (en) 1987-03-02 1988-02-27 New cardiodilatin fragment, process for preparing same and use thereof
DE8888901838T DE3878231T2 (de) 1987-03-02 1988-02-27 Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung.

Publications (2)

Publication Number Publication Date
DE3878231D1 true DE3878231D1 (de) 1993-03-18
DE3878231T2 DE3878231T2 (de) 1993-05-27

Family

ID=27195544

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888901838T Expired - Lifetime DE3878231T2 (de) 1987-03-02 1988-02-27 Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung.

Country Status (7)

Country Link
EP (1) EP0349545B1 (de)
JP (1) JP2819467B2 (de)
AT (1) ATE85345T1 (de)
AU (1) AU614738B2 (de)
DE (1) DE3878231T2 (de)
DK (1) DK174112B1 (de)
WO (1) WO1988006596A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262521A (en) * 1991-06-07 1993-11-16 Sri International Isolated atrial peptide-degrading enzyme and novel compounds useful as inhibitors thereof
DE4216133A1 (de) * 1992-05-15 1993-11-18 Bissendorf Peptide Gmbh Anwendung von Urodilatin bei Lungen- und Bronchialerkrankungen
US5665704A (en) * 1993-11-12 1997-09-09 Genentech, Inc. Receptor specific atrial natriuretic peptides
US6525022B1 (en) 1993-11-12 2003-02-25 Genentech, Inc. Receptor specific atrial natriuretic peptides
US5846932A (en) * 1993-11-12 1998-12-08 Genentech, Inc. Receptor specific atrial natriuretic peptides
EP0763061B1 (de) * 1994-06-02 2002-10-30 Forssmann, Wolf-Georg, Prof. Dr. med. Verfahren zur herstellung von cardiodilatin-fragmenten, hochgereinigte cardiodilatin-fragmente und zwischenprodukte zu deren herstellung
DE19535445A1 (de) * 1995-09-23 1997-03-27 Boehringer Mannheim Gmbh Verfahren zur Herstellung von natriuretischen Peptiden über Streptavidin-Fusionsproteine
JP2000500019A (ja) * 1995-11-16 2000-01-11 ロシュ ダイアグノスティクス ゲゼルシャフト ミット ベシュレンクテル ハフツング ストレプトアビジン融合タンパク質経由でのペプチドの生産方法
DE19951471A1 (de) * 1999-10-26 2001-05-03 Forssmann Wolf Georg Verwendung von Urodilatin zur Behandlung chronischer Niereninsuffizienz mit Nierenrestfunktionen
DE10116552A1 (de) 2001-04-03 2002-10-10 Abc Armbruster Biochemicals Verfahren zur Bestimmung der wirksamen Parathormon-Aktivität in einer Probe
US7732406B2 (en) 2005-04-07 2010-06-08 Cardiopep Pharma Gmbh Use of natriuretic peptide for treating heart failure
CA2647146A1 (en) 2006-03-30 2007-10-11 Palatin Technologies, Inc. Linear natriuretic peptide constructs
MX2008012663A (es) 2006-03-30 2008-10-13 Palatin Technologies Inc Constructos ciclicos de peptidos natriureticos.
US8580746B2 (en) 2006-03-30 2013-11-12 Palatin Technologies, Inc. Amide linkage cyclic natriuretic peptide constructs
ES2575397T3 (es) 2007-09-11 2016-06-28 Cardiopep Pharma Gmbh Uso de péptidos natriuréticos para el tratamiento de síndromes de angioedema
EP2631247A1 (de) 2012-02-22 2013-08-28 Immundiagnostik AG Mittel und Verfahren zum Messen des Parathyroid-Hormons bei unter oxidativem Stress leidenden Patienten
ES2689193T3 (es) 2013-03-08 2018-11-08 Immundiagnostik Ag La hormona paratiroidea biológica activa no oxidada determina mortalidad en pacientes en hemodiálisis
EP3740762B1 (de) 2018-01-17 2024-07-31 Immundiagnostik AG Biomarker zur voraussage von koronararterienerkrankung
FR3099056B1 (fr) * 2019-07-26 2022-08-12 Univ Rouen Normandie Utilisation de l’ANP pour détruire les biofilms bactériens

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0780907B2 (ja) * 1984-04-19 1995-08-30 シオス・ノバ・インク 新規な心房性ナトリウム尿排泄亢進性及び血管拡張性ポリペプチド
DE3443257A1 (de) * 1984-11-28 1986-05-28 Bissendorf Peptide GmbH, 3002 Wedemark Mittel enthaltend vollsynthetisches alpha-humanes atriales natriuretisches peptid (alpha-hanap)

Also Published As

Publication number Publication date
DK174112B1 (da) 2002-06-24
JPH02502636A (ja) 1990-08-23
EP0349545A1 (de) 1990-01-10
WO1988006596A1 (en) 1988-09-07
AU1348188A (en) 1988-09-26
DK610888A (da) 1988-11-02
ATE85345T1 (de) 1993-02-15
AU614738B2 (en) 1991-09-12
DK610888D0 (da) 1988-11-02
EP0349545B1 (de) 1993-02-03
JP2819467B2 (ja) 1998-10-30
DE3878231T2 (de) 1993-05-27

Similar Documents

Publication Publication Date Title
DE3878231D1 (de) Neues cadiodilatin-fragment, prozess zu dessen herstellung und dessen anwendung.
DK0423302T3 (da) Anvendelse af hidtil ukendte DNA-fragmenter som kodende sekvens for et signalpeptid til sekretion af modne proteiner i rekombinant gær, ekspressionskassetter, transformeret gær og tilsvarende fremgangsmåde til fremstilling af proteiner
ES2075155T3 (es) Separacion enzimatica de una secuencia de una proteina con amino terminal.
ES8601108A1 (es) Procedimiento para la obtencion de eglinas b o c modificadas
ES2059354T3 (es) Un metodo para producir un polipeptido.
NO174351C (no) Fremgangsmåte for fremstilling av human insulinforlöper samt DNA-sekvens og vektor til anvendelse av fremgangsmåten
ATE135712T1 (de) Polypeptid, dessen verfahren zur herstellung und dieses enthaltende pharmazeutische zusammensetzung und deren benutzung
AR246765A1 (es) Novedosos genes y secuencias de adn del factor i del crecimiento del tipo de la preproinsulina humana.
IL85020A (en) Pancreatic secretory trypsin inhibitor variants, their production, expression vectors and recombinant hosts therefor and pharmaceutical compositions containing them
ATE7138T1 (de) Verfahren zur herstellung von 1,5-didesoxy-1,5imino-d-glucitol und dessen n-derivaten.
DE3582895D1 (de) Peptid, dessen herstellung und benutzung.
ES548052A0 (es) Procedimiento para preparar peptidos
DE3568048D1 (en) Process for the synthesis of peptides
MX167236B (es) Peptidos sinteticos de timosina -1 y metodo para su obtencion
EP0315118A3 (de) Endothelin kodierendes DNA und dessen Verwendung
DE69529750D1 (de) Verbesserungen in der herstellung von proteinen in wirtszellen
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
PT88913A (pt) Processo para a preparacao da proteina pp4-x anticoagulante
PT73587A (en) Process for preparing novel peptides
IT1250653B (it) Enzimi fibrinolitici ammidati e loro precursori, e processi per la loro preparazione.
ATE110775T1 (de) Verfahren zur herstellung von hirudin.
NO921496L (no) Fremgangsmaate for fremstilling av et peptid eller proteinbeslektet med det melanomaforbundne p97-antigen
JPS6450852A (en) Manufacture of l,l or d,d or racemic n6- benzyloxycarbonyl-2,6-diaminopimelamic acid
JPS642577A (en) Amino acid sequence of human alpha2-plasmin inhibitor and gene fragment
IT1226430B (it) Difluoroalometossifenil-derivato e miticida che contiene detto derivato come ingrediente attivo

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: PHARIS BIOTEC GMBH, 30625 HANNOVER, DE